Sponsors and Exhibitors

Our industry sponsors are at the core of the research and development that contributes to the improvement of patient care. They provide the essential data on products and resources to enable physicians in daily practice and improve patient outcomes.

EAACI’s Hybrid congress will provide sponsors and exhibitors further unique opportunities to reach the EAACI community worldwide. The very latest developments will be presented, discussed and debated during the EAACI Hybrid Congress 2024.


For more information on the sponsor opportunities visit our EAACI Sponsor Online Platform (ESOP) by clicking here.

For further sponsor information, please visit our Industry Service Centre – click here (NB: to be able to access this specific area link on the ESOP you must have a unique user name and password)

Ensure you are at the forefront of research, and support Allergy and Immunology development by sharing Industry activities and attending the following:

Industry Symposia

Delegates are invited to attend a series of Industry Symposia included in the scientific programme of the Congress. All symposia and workshops offer relevant data on up-to-date scientific information and developments from the Industry.


Join us in meeting with key industry experts, exchange knowledge on critical areas of development and research in allergy and immunology.

The onsite and virtual exhibitions will be open according to the main scientific programme timetable, subject to final adjustments.

  • Virtual Exhibition – open from 31 May 2024 until 30 November 2024
  • Start of onsite Exhibition: 31 May 2024 – 9:00 (CET)
  • End of onsite Exhibition: 2 June 2024 – 17:30 (CET)



EAACI Mobile App

Company & Product Descriptions available in the EAACI Events mobile app.

The EAACI smartphone app enables you to explore the EAACI Hybrid Congress 2024 programme and exhibition at your fingertips.


Download the EAACI Mobile App before congress through the following PDF below

EAACI Mobile App Info



EAACI would like to acknowledge the following EAACI 2024 Annual Congress exhibitors and sponsors:

  • ALK – Abelló
  • Allergopharma
  • Allergy Therapeutics
  • American Academy of Allergy, Asthma & Immunology (AAAAI)
  • ASAC Pharmaceutical Immunology
  • AstraZeneca PLC
  • Astria Therapeutics
  • ARS Pharma
  • Bedfont Scientific Ltd
  • BioCryst Pharmaceuticals
  • Blueprint Medicines
  • Bühlmann Laboratories
  • Celldex Therapeutics
  • Celltrion, Inc.
  • Chemotechnique MB Diagnostics
  • CSL Behring
  • DBV Technologies
  • Diater
  • Dr. Fooke-Achterrath Laboratorien GmbH
  • FAES Farma
  • GlaxoSmithKline plc
  • HAL Allergy
  • Hippo DX
  • Hycor Biomedical
  • InBio
  • Inmunotek
  • Intellia Therapeutics
  • Ionis Pharmaceutical
  • Jasper Therapeutics
  • Karger Publishers
  • KalVista Pharmaceuticals
  • LETI Pharma
  • Lofarma
  • MacroArray Diagnostics
  • Nestle Purina PetCare
  • Nexkin Medical
  • NIOX Healthcare
  • Noucor
  • Novartis Pharma
  • Otsuka Pharmaceutical Europe
  • Pharming Group NV
  • Pharvaris
  • Probelte Pharma
  • Protia Inc.
  • Reacta Healthcare
  • Red Maple Trials
  • Roxall Group
  • Sanofi Regeneron
  • Scibase
  • Siemens Healthineers
  • Stallergenes
  • Takeda
  • Tamakona
  • Thermo Fisher Scientific
  • World Allergy Organisation (WAO)
  • Wisepress Publishers

We are happy to assist companies in selecting the various Industry options at the EAACI Hybrid Congress 2024. Please contact us at sponsors@eaaci.org to discuss the various options available.

Stay in touch

Want to get the news about all the EAACI events?
Subscribe for our events-newsletter here.